On the day, Astec Lifesciences recorded a gain of 8.34%, significantly outperforming the Pesticides & Agrochemicals sector by 6.73%. This surge contrasts with the Sensex’s more modest advance of 0.22%, which itself reached a new 52-week high at 85,377.00 points. The benchmark index opened at 85,470.92, up 284.45 points or 0.33%, and maintained a bullish stance by trading above its 50-day moving average, which remains above the 200-day moving average.
The stock’s intraday volatility was notable, registering 10.85% based on the weighted average price, indicating active price swings throughout the session. Astec Lifesciences’ price movement today was above its 5-day and 20-day moving averages, signalling short-term momentum, although it remained below the longer-term 50-day, 100-day, and 200-day moving averages.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Examining the recent performance trends, Astec Lifesciences has recorded a 9.38% gain over the past day, contrasting with the Sensex’s 0.22% rise. Over the last week, the stock’s performance stands at 9.27%, again outpacing the Sensex’s 1.06%. However, the one-month trend shows a decline of 2.63%, while the Sensex advanced by 1.20% during the same period.
Longer-term data reveals a more challenging trajectory for Astec Lifesciences. Over three months, the stock’s value has declined by 17.74%, whereas the Sensex has appreciated by 4.30%. The one-year performance shows a reduction of 36.13%, compared to the Sensex’s 10.05% gain. Year-to-date figures indicate a 31.84% decrease for the stock, while the Sensex has increased by 9.26%. Over three and five years, the stock has declined by 67.54% and 27.20% respectively, contrasting with the Sensex’s gains of 38.46% and 94.56%. Over a decade, Astec Lifesciences has recorded a cumulative gain of 182.82%, trailing the Sensex’s 230.04% rise.
Astec Lifesciences operates within the Pesticides & Agrochemicals industry, a sector that has experienced varied performance relative to the broader market. The stock’s recent intraday strength comes amid a market environment where mega-cap stocks are leading gains, contributing to the Sensex’s positive momentum.
Is Astec Lifesciences your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Trading activity in Astec Lifesciences today was marked by significant volatility, which often attracts short-term traders seeking to capitalise on price fluctuations. The stock’s position above its short-term moving averages suggests some immediate momentum, although its placement below longer-term averages indicates that broader trends remain subdued.
Market participants will note that while the Sensex continues to trade in a bullish zone supported by its moving averages, Astec Lifesciences’ performance remains more volatile and less aligned with the broader market’s upward trajectory. This divergence highlights the stock’s distinct trading dynamics within its sector and market capitalisation category.
Overall, Astec Lifesciences’ intraday high of Rs 670.6 and the accompanying 8.34% gain on 20 Nov 2025 represent a notable episode of trading strength. This performance stands out against the backdrop of the Sensex’s steady gains and the sector’s more moderate movements, underscoring the stock’s capacity for sharp price action within a single session.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
